We are live on ! Find out more

450 hedge funds and large institutions have $9.66B invested in Sanofi in 2016 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 165 increasing their positions, 148 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $43M | Put options by funds: $19.4M

11% more repeat investments, than reductions

Existing positions increased: 165 | Existing positions reduced: 148

11% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 38

0.77% more ownership

Funds ownership: 18.85%19.62% (+0.77%)

0% more funds holding

Funds holding: 450450 (0)

0% more funds holding in top 10

Funds holding in top 10: 99 (0)

5% less capital invested

Capital invested by funds: $10.1B → $9.66B (-$485M)

Holders
450
Holders Change
Holders Change %
0%
% of All Funds
11.97%
Holding in Top 10
9
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.24%
New
42
Increased
165
Reduced
148
Closed
38
Calls
$43M
Puts
$19.4M
Net Calls
+$23.6M
Net Calls Change
+$16.1M

SNY Hedge Fund Activity: Q3 2016 in Review

450 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q3 2016, worth a combined $9.66B — down 4.8% from $10.1B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new SNY positions and 38 closed out — a net gain of 4 holders — while 165 added to existing stakes and 148 trimmed.

The largest buyer was Dodge & Cox, adding an estimated $165M. The largest seller was Harris Associates, cutting an estimated $92.2M.

  • 450 institutional investors held Sanofi (SNY) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $9.66B of Sanofi stock for Q3 2016, down 4.8% quarter-over-quarter.
  • 42 funds opened new Sanofi positions in Q3 2016 and 38 closed out, a net change of +4 holders.
  • The largest Sanofi buyer in Q3 2016 was Dodge & Cox, an estimated $165M added.
  • The largest Sanofi seller in Q3 2016 was Harris Associates, an estimated $92.2M sold.

Based on aggregated 13F filings for Q3 2016.